Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123724234 | 12372423 | 4 | F | 20160719 | 20160516 | 20160725 | EXP | JP-GILEAD-2016-0212880 | GILEAD | 69.00 | YR | E | F | Y | 0.00000 | 20160725 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123724234 | 12372423 | 1 | PS | SOVALDI | SOFOSBUVIR | 1 | Oral | UNK | 204671 | TABLET | |||||||||
| 123724234 | 12372423 | 2 | SS | REBETOL | RIBAVIRIN | 1 | Oral | 400 MG, BID | Y | U | 0 | 400 | MG | CAPSULE | BID | ||||
| 123724234 | 12372423 | 3 | SS | REBETOL | RIBAVIRIN | 1 | Oral | 2 DF, UNK | Y | U | 0 | 2 | DF | CAPSULE | |||||
| 123724234 | 12372423 | 4 | C | GLUFAST | MITIGLINIDE | 1 | Oral | 0 | |||||||||||
| 123724234 | 12372423 | 5 | C | METGLUCO | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | |||||||||||
| 123724234 | 12372423 | 6 | C | GLACTIV | SITAGLIPTIN | 1 | Oral | 0 | |||||||||||
| 123724234 | 12372423 | 7 | C | SENNOSIDE /00571901/ | SENNOSIDES A AND B | 1 | Oral | 0 | |||||||||||
| 123724234 | 12372423 | 8 | C | LENDORMIN | BROTIZOLAM | 1 | Oral | 0 | |||||||||||
| 123724234 | 12372423 | 9 | C | MEVALOTIN | PRAVASTATIN SODIUM | 1 | Oral | 0 | |||||||||||
| 123724234 | 12372423 | 10 | C | BUP-4 | PROPIVERINE | 1 | Oral | 0 | |||||||||||
| 123724234 | 12372423 | 11 | C | TAKEPRON | LANSOPRAZOLE | 1 | Oral | 0 | |||||||||||
| 123724234 | 12372423 | 12 | C | CELECOX | CELECOXIB | 1 | Oral | 0 | |||||||||||
| 123724234 | 12372423 | 13 | C | MAGMITT | MAGNESIUM OXIDE | 1 | Oral | 0 | |||||||||||
| 123724234 | 12372423 | 14 | C | MUCOSTA | REBAMIPIDE | 1 | Oral | 0 | |||||||||||
| 123724234 | 12372423 | 15 | C | SUNRYTHM | PILSICAINIDE HYDROCHLORIDE | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123724234 | 12372423 | 1 | Hepatitis C |
| 123724234 | 12372423 | 2 | Hepatitis C |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123724234 | 12372423 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123724234 | 12372423 | Haemoglobin decreased | |
| 123724234 | 12372423 | Nausea | |
| 123724234 | 12372423 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123724234 | 12372423 | 1 | 20160417 | 2016 | 0 | |
| 123724234 | 12372423 | 2 | 201605 | 0 |